PLX038 clinical trials

"TOPOLOGY" : A phase II study to evaluate the efficacy and toxicities of PLX038, in patients with locally advanced or metastatic triple-negative breast cancer

This study is testing a new medicine called PLX038 for people with advanced triple-negative breast cancer. Researchers want to see if it can shrink tumours and how safe it is. It's an early-stage study to find out more about this potential treatment.